Page last updated: 2024-09-04

2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and 8-epi-prostaglandin f2alpha

2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with 8-epi-prostaglandin f2alpha in 1 studies

Compound Research Comparison

Studies
(2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman)
Trials
(2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman)
Recent Studies (post-2010)
(2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman)
Studies
(8-epi-prostaglandin f2alpha)
Trials
(8-epi-prostaglandin f2alpha)
Recent Studies (post-2010) (8-epi-prostaglandin f2alpha)
45471,863248723

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, WL; Jeanes, YM; Lodge, JK; Proteggente, AR1

Other Studies

1 other study(ies) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and 8-epi-prostaglandin f2alpha

ArticleYear
Cigarette smokers have decreased lymphocyte and platelet alpha-tocopherol levels and increased excretion of the gamma-tocopherol metabolite gamma-carboxyethyl-hydroxychroman (gamma-CEHC).
    Free radical research, 2004, Volume: 38, Issue:8

    Topics: Adult; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Blood Platelets; Chromans; Dinoprost; Female; Humans; Lymphocytes; Male; Middle Aged; Propionates; Smoking; Uric Acid

2004